Franklin Pierce
Well-Known Member
- Joined
- May 4, 2014
- Messages
- 28,523
- Likes
- 32,527
Should the distribution of donated kidneys be decided based on patients' race?
Medical ethics would seem obviously to forbid such a thing. Yet this is what's happening. You can thank the Left's diversity, equity, and inclusion agenda, which has poisoned not only the nation's learning institutions and corporations but also its hospitals.
As the medical nonprofit group Do No Harm reported this month, the Organ Procurement and Transplantation Network and the United Network for Organ Sharing will abandon medicine-based decisions on kidney transplants. This, they say, is because kidneys are not going to enough black patients when objective medical criteria are applied. The scales are therefore to be tilted to achieve "equity."
The new formula will favor black patients in a way that ignores human biology and makes no medical sense. The new regime requires doctors to ignore a medically documented and racially significant difference in a specific chemical marker of kidney function. From now on, these organizations will treat the readings as if there is no difference by race. This will push non-black patients further back in line despite desperate need. Many black patients will move forward for replacement kidneys even if their eligibility or need for a transplant is less than that of some white patients.
No to distributing kidneys based on race
Medical ethics would seem obviously to forbid such a thing. Yet this is what's happening. You can thank the Left's diversity, equity, and inclusion agenda, which has poisoned not only the nation's learning institutions and corporations but also its hospitals.
As the medical nonprofit group Do No Harm reported this month, the Organ Procurement and Transplantation Network and the United Network for Organ Sharing will abandon medicine-based decisions on kidney transplants. This, they say, is because kidneys are not going to enough black patients when objective medical criteria are applied. The scales are therefore to be tilted to achieve "equity."
The new formula will favor black patients in a way that ignores human biology and makes no medical sense. The new regime requires doctors to ignore a medically documented and racially significant difference in a specific chemical marker of kidney function. From now on, these organizations will treat the readings as if there is no difference by race. This will push non-black patients further back in line despite desperate need. Many black patients will move forward for replacement kidneys even if their eligibility or need for a transplant is less than that of some white patients.
No to distributing kidneys based on race
